Dr. Salmaan Qureshi is a highly respected consultant ophthalmologist with three decades of experience specialising in Medical Retina and complex cataract surgery. After graduating from the University of Adelaide in 1991, he completed ophthalmology registrar training in South Australia before undertaking two prestigious fellowships — first in Anterior Segment reconstruction Corneal transplantation and complex cataract surgery at Leeds General Infirmary. His second fellowship was in Medical Retina at Moorfields Eye Hospital in London, under the mentorship of Professor Alan Bird.

Since joining the Royal Victorian Eye and Ear Hospital (RVEEH) as a Consultant in 2001, Dr Qureshi has been instrumental in transforming the landscape of retinal care in Australia and teaching a generation of general ophthalmologists and retinal specialists. In 2006, he introduced anti-VEGF therapy (Avastin) for retinal vascular disease to the hospital, making RVEEH the first in the country to offer this now-standard treatment. His commitment to advancing ophthalmic care continued in 2013 with the co-initiation of the DIMECAT trial alongside Prof Lyndell Lim — a study poised to redefine the way cataract surgery is approached in patients with diabetic macular disease.

Dr. Qureshi was the head of the medical retina service between 2020 and 2024.

Dr Qureshi has served as principal or co-investigator in several landmark clinical trials, including ANCOR, MARINA, RESOLVE, and EXCITE, all of which have played pivotal roles in shaping current standards of care for blinding retinal diseases. His contributions to the academic and scientific community extend beyond clinical research. As Editor-in-Chief of Clinical and Experimental Ophthalmology from 2010 to 2020, he elevated the journal’s impact factor and reputation, establishing it as the highest-ranked medical journal (in any medical specialty) published in Australia and New Zealand.

In addition to his research and clinical work, Dr Qureshi has published extensively in peer-reviewed journals, contributed to ophthalmic textbooks, and developed an interactive Atlas of Retinal Disease for mobile platforms (Apple iphone and ipad). His areas of expertise include diabetic retinopathy, age-related macular degeneration, retinal vascular disease, and inherited retinal dystrophies. He has performed several procedures in complex cataract surgery, intravitreal injections, and retinal laser therapy.

Dr Qureshi currently consults patients in Doncaster and Vermont South, where he continues to deliver compassionate, cutting-edge care to those affected by vision-threatening retinal conditions.